BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply

U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the JYNNEOS vaccine to allow healthcare providers to use the vaccine by i...

August 10, 2022 | News

Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant

The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technolog...

August 08, 2022 | News

Polyplus Introduces Transgene Plasmid Engineering Services for Optimized Viral Vector Manufacturing

Following the early 2022 acquisition of e-Zyvec, integration activities have focused on providing a deeper level of solutions support to customers. Using t...

August 03, 2022 | News

BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology

Research team ‘EDC’ will study ‘Extrachromosomal DNA in Cancer’. With this project, the two partners launch their ninth collabor...

August 02, 2022 | News

Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance

The workshop program included training on the importance of sustainability in manufacturing practices of antibiotics, as well as a presentation of th...

July 27, 2022 | News

Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy

Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously d...

July 27, 2022 | News

CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President

CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today...

July 26, 2022 | News

Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug

As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis, Daewoong Pharmaceutical's new ...

July 21, 2022 | News

Oncoshot Enters Collaboration Agreement With Omico

Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented...

July 20, 2022 | News

WuXi STA Opens a New Large Scale Continuous Manufacturing Plant

WuXi STA, a subsidiary of WuXi AppTec, announced that it has opened a new continuous manufacturing (flow chemistry) plant at its Changzhou campus in ...

July 20, 2022 | News

Biotium Introduces New Line of Antibodies for Exosome Detection

Biotium, a leading supplier and inventor of fluorescent cellular probes for life science research, announces the release of new...

July 18, 2022 | News

China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth's NR082 in LHON

NR082 (rAAV2-ND4), a recombinant adeno-associated viral vector, serotype 2, containing human ND4 codon-optimized gene under the control of the cy...

July 18, 2022 | News

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announce...

July 14, 2022 | News

Singapore Based SCG Cell Therapy Announces U.S FDA Clearance

ingapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) ...

July 12, 2022 | News

Stay Connected